Medicus Pharma Ltd. Completes Enrolment of Ninety (90) Patients for Phase 2 Clinical Study (SKNJCT-003) to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin

Medicus Pharma Ltd. Completes Enrolment of Ninety (90) Patients for Phase 2 Clinical Study (SKNJCT-003) to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin GlobeNewswire December 15, 2025 THE COMPANY EXPECTS TO RELEASE TOPLINE RESULTS FOR SKNJCT-003 PHASE 2 CLINICAL TRIAL BEFORE THE END OF Q1 2026 AND REQUEST END-OF-PHASE 2 (EOP2) WITH THE […]

Rio Silver Completes 100% Acquisition of High-Grade Maria Norte Silver Project in Peru’s Historic Huachocolpa District

Rio Silver Completes 100% Acquisition of High-Grade Maria Norte Silver Project in Peru's Historic Huachocolpa District Acquisition marks transformational step toward near-term silver development as global demand surges across AI, electronics, and renewable-energy markets GlobeNewswire December 15, 2025 VANCOUVER, British Columbia, Dec. 15, 2025 (GLOBE NEWSWIRE) — Rio Silver Inc. (TSX-V: RYO | OTC: RYOOF)

McFarlane Receives Exploration Permit

McFarlane Receives Exploration Permit GlobeNewswire December 15, 2025 Indigenous-Led Partnerships to Perform Exploration Drilling on the Juby Gold Project TORONTO, Dec. 15, 2025 (GLOBE NEWSWIRE) — McFarlane Lake Mining Limited (“McFarlane” or the “Company“) (CSE: MLM, OTC: MLMLF) is pleased to announce the receipt of its Exploration Permit for upcoming work at the 100%-owned Juby

Habit Celebrates Covina Restaurant Launch

Habit Celebrates Covina Restaurant Launch GlobeNewswire December 15, 2025 New California Habit Drive-Thru Restaurant to Open Doors on December 22Hold Pre-Opening VIP Event on December 20 IRVINE, Calif., Dec. 15, 2025 (GLOBE NEWSWIRE) — Habit, the California-based restaurant company renowned for its award-winning Charburgers grilled over an open flame, signature sandwiches, fresh salads, and more,

Trident Resources Announces the Strategic Addition of Paul Kremer, M.Sc., as Exploration Manager

Trident Resources Announces the Strategic Addition of Paul Kremer, M.Sc., as Exploration Manager GlobeNewswire December 15, 2025 Vancouver, BC, Dec. 15, 2025 (GLOBE NEWSWIRE) — Trident Resources Corp. (TSX-V: ROCK) (OTCQB: TRDTF) (“Trident” or the “Company”) is pleased to announce the appointment of Paul Kremer as Exploration Manager working alongside the existing geological team led

Aecon announces next quarterly dividend

Aecon announces next quarterly dividend GlobeNewswire December 15, 2025 TORONTO, Dec. 15, 2025 (GLOBE NEWSWIRE) — Aecon Group Inc. (TSX: ARE) (“Aecon”) announced today that the Board of Directors approved its next quarterly dividend of 19 cents per share. The dividend will be paid on January 5, 2026 to shareholders of record as of December

Sportradar Shareholders Elect Breon Corcoran, CEO of IG Group, to Board of Directors

Sportradar Shareholders Elect Breon Corcoran, CEO of IG Group, to Board of Directors Globally renowned executive in betting, gaming, and fintech boasts track record of driving innovation, digital transformation, and international growth GlobeNewswire December 15, 2025 ST. GALLEN, Switzerland, Dec. 15, 2025 (GLOBE NEWSWIRE) — Sportradar Group AG (NASDAQ: SRAD), a leading global sports technology

3D Systems Announces FDA 510(k) Clearance Expanding VSP Orthopedics Indications to Include Skeletally Mature Adolescents

3D Systems Announces FDA 510(k) Clearance Expanding VSP Orthopedics Indications to Include Skeletally Mature Adolescents Removes Key Adoption Barriers in Pediatric/Adolescent Oncology and Deformity Market GlobeNewswire December 15, 2025 ROCK HILL, S.C., Dec. 15, 2025 (GLOBE NEWSWIRE) — 3D Systems (NYSE: DDD) today announced that the U.S. Food and Drug Administration has granted 510(k) clearance

Lost Money on MoonLake Immunotherapeutics (MLTX)? Contact Levi & Korsinsky Before December 15, 2025 to Join Class Action

NEW YORK, NY / ACCESS Newswire / December 15, 2025 / If you suffered a loss on your MoonLake Immunotherapeutics (NASDAQ:MLTX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://stockdropcenter.com/moonlake-lawsuit-submission-form?prid=180342&wire=1&utm_campaign=12 or call (212) 363-7500 to speak to our team of experienced shareholder

Securities Lawsuit Alert: Synopsys, Inc. (SNPS) – Contact Levi & Korsinsky Before December 30, 2025

NEW YORK, NY / ACCESS Newswire / December 15, 2025 / If you suffered a loss on your Synopsys, Inc. (NASDAQ:SNPS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://stockdropcenter.com/synopsys,-inc.-lawsuit-submission-form?prid=180341&wire=1&utm_campaign=3 or call (212) 363-7500 to speak to our team of experienced shareholder

Scroll to Top